K
PharmaceuticalsSmallcap
Kopran Limited is engaged in pharmaceutical business. The Company's business units include Finished Dosage Forms, Active Pharmaceutical Ingredients, Research and Development, and Consumer Healthcare.
| Key Metrics | This Stock | Category (Avg) |
| PE Ratio | 16.28 | 36.22 |
| PB Ratio | 1.21 | 5.71 |
| Dividend Yield | 2.31% | 0.60% |
Understand what these metrics mean.
For peer comparison & financials,